Sanofi-Aventis Wins Canadian Ruling In Generic Plavix Case

Thursday, 28 Dec 2006 | 2:26 PM ET

Sanofi-Aventis said it has won in an appeal by Canadian generic drugmaker Apotex which is prohibited from selling cheaper copies of Sanofi's bloodthinner Plavix in Canada.

French drugmaker Sanofi-Aventis and U.S. partner Bristol-Myers Squibbsaid in a statement the court had dismissed an appeal by Apotex to sell a generic version of Plavix, a blockbuster drug that Bristol-Myers sells for Sanofi in the United States.

  Price   Change %Change


Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • "The economy and the stock market are not always linked," says Henry Blodget, Business Insider editor-in-chief & CEO, stating three reasons why he thinks the market is set up for bad returns.

  • Will Power, Robert W. Baird & Co. senior research analyst, discusses expectations the Q1 quarterly earnings of Netflix and their market opportunity in the U.S. and abroad. Henry Blodget, Business Insider, provides insight.

  • Chinese e-commerce giant Alibaba is expected to file for an IPO as soon as this week and could raise up to $15 billion when the company eventually goes public, reports CNBC's Josh Lipton.